Pharm

Elbasvir Grazoprevir

search

Elbasvir Grazoprevir, Elbasvir/Grazoprevir, Zepatier

  • Indications
  1. See Hepatitis C Antiviral Regimen
  2. Hepatitis C Genotype 1a (alternative agent)
  3. Hepatitis C Genotype 1b
  4. Hepatitis C Genotype 4
  5. Advantages
    1. Priced lower than other Genotype I regimens
    2. May be used despite GFR <30 ml/min
  • Contraindications
  1. See Hepatitis C Antiviral Regimen
  2. Child Pugh Class B or C (or CTP score >=7)
  • Mechanism
  1. Elbasvir is a NS5A Protein Inhibitor (...asvirs)
  2. Grazoprevir is a NS3/4A Protease Inhibitor (...previrs)
  • Dosing
  1. Take once daily for 12 weeks
  • Evaluation
  1. See Hepatitis C Antiviral Regimen for Pre and post-treatment protocols
  • Efficacy
  1. As effective as other agents used in Genotype 1 Hepatitis C infections
  • Adverse Effects
  1. See Hepatitis C Antiviral Regimen
  2. Common (>5%)
    1. Fatigue
    2. Headache
    3. Nausea
  3. Serious
    1. Liver injury or hepatic failure
      1. Do not use in Child Pugh Class B or C
  • Drug Interactions
  • Monitoring
  1. See Hepatitis C Antiviral Regimen
  2. Recheck Liver Function Tests at 8 weeks
    1. If using a 16 week course, also recheck at 12 weeks
  • References
  1. (2023) Presc Lett, Hepatitis C Treatment Overview, Resource #390902